Northeastern professor lands NIH grants for nanotech drug delivery

By Mass High Tech staff

Video Gallery

MHT's Jackie Noblett: Maine becoming a hub for pet-oriented biotechs

MHT's Julie Donnelly: Pharmaceuticals find drug development partners in colleges

MHT's Julie Donnelly: Life science startups finding investments

Spin Transfer whips up $36M in first round [February 13, 2012]

Oxford Immunotec taps Altieri as CFO [February 13, 2012]

SeraCare selling to Linden for $82M [February 13, 2012]

UtiliData finds more funding from Braemer [February 13, 2012]

The National Institutes of Health has awarded two grants to Northeastern University professor of pharmaceutical sciences Mansoor Amiji and his team of researchers to study a treatment for cancer, Alzheimer’s, schizophrenia and HIV/AIDS.

Amiji, with his research team of chemistry and biology professors Robert Hanson and Max Diem, won a two-year, $350,000 grant to study the use of ceramide, a cell killer, that can aid in killing cancer cells that may become resistant after initial chemotherapy treatment.

Amiji and chemical engineering professor Rebecca Carrier also won a two-year, $475,000 grant from the National Institute of Neurological Diseases and Stroke to study a “nano-emulsion” system aimed at enabling drug delivery “to cross the blood-brain barrier.” If successful, the treatment could help patients with Parkinson’s disease or HIV/AIDS receive drugs in parts of the brain where the diseases may “hide,” according to a press release from Northeastern University.

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.